methylbufotenin and 4-iodo-2,5-dimethoxyphenylisopropylamine, (r)-isomer

methylbufotenin has been researched along with 4-iodo-2,5-dimethoxyphenylisopropylamine, (r)-isomer in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Glennon, RA1
Conklin, DS; Fitzgerald, LW; Hartig, PR; Iyer, G; Kostich, WA; Krause, CM; Largent, BL; Marshall, AP; Patterson, JP; Tran, DP1
Dantanarayana, AP; May, JA; McLaughlin, MA; Sharif, NA; Zinke, PW1

Reviews

1 review(s) available for methylbufotenin and 4-iodo-2,5-dimethoxyphenylisopropylamine, (r)-isomer

ArticleYear
Central serotonin receptors as targets for drug research.
    Journal of medicinal chemistry, 1987, Volume: 30, Issue:1

    Topics: Animals; Humans; Receptors, Serotonin; Research Design; Serotonin

1987

Other Studies

2 other study(ies) available for methylbufotenin and 4-iodo-2,5-dimethoxyphenylisopropylamine, (r)-isomer

ArticleYear
High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT2A and 5-HT2C receptors: evidence favoring the ternary complex and two-state models of agonist action.
    Journal of neurochemistry, 1999, Volume: 72, Issue:5

    Topics: Amphetamines; Binding, Competitive; Cell Line; Ergolines; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Hydrolysis; Isomerism; Ligands; Models, Biological; Phosphatidylinositols; Receptors, Serotonin; Recombinant Proteins; Serotonin Antagonists; Serotonin Receptor Agonists; Spiperone

1999
1-((S)-2-aminopropyl)-1H-indazol-6-ol: a potent peripherally acting 5-HT2 receptor agonist with ocular hypotensive activity.
    Journal of medicinal chemistry, 2006, Jan-12, Volume: 49, Issue:1

    Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Drug; Haplorhini; Head Movements; Humans; Indazoles; Lasers; Mice; Molecular Structure; Ocular Hypertension; Rabbits; Rats; Serotonin 5-HT2 Receptor Agonists

2006